Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

piquindone

Known as: 2,6-dimethyl-3-ethyl-4,4a,5,6,7,8,8a,9-octahydro-4a,8a-1H-pyrrolo(2,3g)isoquinolin-4-one, 3-ethyl-2,6-dimethyl-4,4a,5,6,7,8,8a,9-octahydro-4a,8a-1H-pyrrolo(2,3g)isoquinolin-4-one 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1989
Highly Cited
1989
A range of 3- and 6-substituted 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 with D-1 agonist activity were compared for… Expand
1989
1989
SummaryMolecular graphic design coupled with PCILO and crystallographic results have been used to investigate the three… Expand
1989
1989
A combination of experimental and theoretical methods were used to investigate the stereoelectronic structure of zetidoline, a… Expand
1987
1987
Piquindone (RO22-1319), a new "atypical" neuroleptic, was administered for 2 weeks to 37 schizophrenic patients, and the effects… Expand
1987
1987
The structure of the potent dopamine‐D2 antagonist, raclopride, (S)‐3,5‐dichloro‐N‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐6… Expand
Highly Cited
1986
Highly Cited
1986
The ability of dopamine agonists and antagonists to compete with [3H]spiperone binding to rat striatal membrane preparations at 4… Expand
1986
1986
We have hypothesized that symptoms of Tourette Syndrome (TS) may represent D2 (dopamine-2) receptor hyperactivity. We treated 4… Expand
Highly Cited
1985
Highly Cited
1985
  • S. Stahl
  • Archives of general psychiatry
  • 1985
  • Corpus ID: 41349087
It is now 30 years since the introduction of neuroleptics into clinical practice, and we are still learning more about the… Expand
1984
1984
Ro 22-1319, a novel pyrroloisoquinoline compound, is a potent antipsychotic agent with low potential for extrapyramidal effects… Expand